Overview

Osteoporosis Treatment in Post-menopausal Women

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The study will be conducted to assess the depressive symptoms and related markers in the postmenopausal female after anti-osteoporosis treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Taichung Veterans General Hospital
Treatments:
Alendronate
Raloxifene Hydrochloride